By Benjamin Horney ( March 13, 2015, 1:59 PM EDT) -- Private equity-backed generic-drugs maker Par Pharmaceutical Holdings Inc. said on Friday that it is gearing up to launch an initial public offering, and according to IPO exchange-traded fund manager Renaissance Capital, the New Jersey-based company's offering could be worth upwards of $700 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.